These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10332540)

  • 1. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: I. Adenosine agonists.
    Dixon DA; Fenix LA; Kim DM; Raffa RB
    Ann Pharmacother; 1999 Apr; 33(4):480-8. PubMed ID: 10332540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: II. Glutamate (Ant)agonists.
    Carfagno ML; Hoskins LA; Pinto ME; Yeh JC; Raffa RB
    Ann Pharmacother; 2000 Jun; 34(6):788-97. PubMed ID: 10860140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids.
    Citver AS; Shields AM; Ciaccia LM; Schulingkamp RJ; Raffa RB
    J Clin Pharm Ther; 2002 Jun; 27(3):161-8. PubMed ID: 12081629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A2A receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected fibroblast cells.
    Dasgupta S; Ferré S; Kull B; Hedlund PB; Finnman UB; Ahlberg S; Arenas E; Fredholm BB; Fuxe K
    Eur J Pharmacol; 1996 Dec; 316(2-3):325-31. PubMed ID: 8982704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential for antipsychotic and psychotomimetic effects of A2A receptor modulation.
    Weiss SM; Whawell E; Upton R; Dourish CT
    Neurology; 2003 Dec; 61(11 Suppl 6):S88-93. PubMed ID: 14663018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia.
    Ferré S
    Psychopharmacology (Berl); 1997 Sep; 133(2):107-20. PubMed ID: 9342776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment.
    Urigüen L; García-Fuster MJ; Callado LF; Morentin B; La Harpe R; Casadó V; Lluis C; Franco R; García-Sevilla JA; Meana JJ
    Psychopharmacology (Berl); 2009 Oct; 206(2):313-24. PubMed ID: 19652957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of adenosine A2A receptors in the treatment of schizophrenia.
    Wardas J
    Front Biosci; 2008 May; 13():4071-96. PubMed ID: 18508501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2 heteroreceptor complexes and their receptor-receptor interactions in ventral striatum: novel targets for antipsychotic drugs.
    Fuxe K; Borroto-Escuela DO; Tarakanov AO; Romero-Fernandez W; Ferraro L; Tanganelli S; Perez-Alea M; Di Palma M; Agnati LF
    Prog Brain Res; 2014; 211():113-39. PubMed ID: 24968778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission.
    Tozzi A; Tscherter A; Belcastro V; Tantucci M; Costa C; Picconi B; Centonze D; Calabresi P; Borsini F
    Neuropharmacology; 2007 Nov; 53(6):783-9. PubMed ID: 17889039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptors as treatment targets in schizophrenia.
    Seeman P
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):56-73. PubMed ID: 20643630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function.
    Fuxe K; Ferré S; Canals M; Torvinen M; Terasmaa A; Marcellino D; Goldberg SR; Staines W; Jacobsen KX; Lluis C; Woods AS; Agnati LF; Franco R
    J Mol Neurosci; 2005; 26(2-3):209-20. PubMed ID: 16012194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation.
    Vortherms TA; Watts VJ
    J Pharmacol Exp Ther; 2004 Jan; 308(1):221-7. PubMed ID: 14566008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complexity of the dopaminergic synapses and their modulation by antipsychotics.
    Leuner K; Müller WE
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S15-20. PubMed ID: 16508891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
    Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
    Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions.
    Akhondzadeh S; Shasavand E; Jamilian H; Shabestari O; Kamalipour A
    J Clin Pharm Ther; 2000 Apr; 25(2):131-7. PubMed ID: 10849191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antagonistic interaction between A2B adenosine and D2 dopamine receptors modulates the function of rat carotid body chemoreceptor cells.
    Conde SV; Gonzalez C; Batuca JR; Monteiro EC; Obeso A
    J Neurochem; 2008 Dec; 107(5):1369-81. PubMed ID: 18823369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychotics.
    Martini C; Tuscano D; Trincavelli ML; Cerrai E; Bianchi M; Ciapparelli A; Alessio L; Novelli L; Catena M; Lucacchini A; Cassano GB; Dell'Osso L
    J Psychiatr Res; 2006 Feb; 40(1):81-8. PubMed ID: 16431220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.